登录 | 注册    关注公众号  
微信公众号
搜索
 >  Antibody>CD45 >FABm007-06

PerCP-Cy5.5 Labeled Monoclonal Anti-Human CD45 Antibody, Mouse IgG2a

应用(Application)

Flow Cytometry (Evaluation of the expression of CD45 on Human cells).

种属(Species)

Mouse

亚型(Isotype)

Mouse IgG2a

特异性(Specificity)

This product is a specific antibody specifically reacts with CD45 protein.

种属反应性(Reactivity)

Human

偶联(Conjugate)

PerCP-Cy5.5

Excitation Wavelength: 488 nm

Emission Wavelength: 690 nm

推荐稀释比(Recommended Dilution)

1:20

制剂(Formulation)

Supplied as 0.2 μm filtered solution in PBS, 0.2% BSA, 0.03% Proclin 300, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

存储(Storage)

Please protect from light and avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. Store at 2-8 °C for 12 months.
 

活性(Bioactivity)-FACS

CD45 FACS

Flow cytometric analysis of Human peripheral blood lymphocytes respectively staining with PerCP-CY5.5-Labeled Anti-Human CD45 Antibody, mouse IgG2a (AIRFS225-240625F1-Bulk) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 2.5e5 cells in a final volume of 100 µL), compared with isotype control antibody. PerCP-CY5.5 signal was used to evaluate the binding activity (QC tested).

Protocol

 

背景(Background)

CD45 is a receptor protein tyrosine phosphatase, also known as Ly-5 or leukocyte common antigen. CD45 mainly involves in the initiation of T cell receptor signaling by controlling the activation of the Src family protein-tyrosine kinases Lck and Fyn. CD45 deficiency causes in T- and B-lymphocyte dysfunction in the form of severe combined immune deficiency. It also takes a significant role in autoimmune diseases and cancer as well as in infectious diseases including fungal infections.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
CD45靶点信息
英文全称:Leukocyte common antigen
中文全称:白细胞共同抗原
种类:Homo sapiens
上市药物数量:0详情
临床药物数量:3详情
最高研发阶段:临床三期
查看更多信息
前沿进展
点击查看详细
相关产品
View All CD45

消息提示

请输入您的联系方式,再点击提交!

确定